{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T13:56:12Z","timestamp":1785419772846,"version":"3.56.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jcehepatology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical and Experimental Hepatology"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.jceh.2021.07.001","type":"journal-article","created":{"date-parts":[[2021,7,9]],"date-time":"2021-07-09T04:50:32Z","timestamp":1625806232000},"page":"409-416","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Diabetes Mellitus Increases the Risk of Significant Hepatic Fibrosis in Patients With Non-alcoholic Fatty Liver Disease"],"prefix":"10.1016","volume":"12","author":[{"given":"Sandeep","family":"Chhabra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sukhraj P.","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7163-0454","authenticated-orcid":false,"given":"Arshdeep","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Varun","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amninder","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3601-4565","authenticated-orcid":false,"given":"Namita","family":"Bansal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajit","family":"Sood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jceh.2021.07.001_bib1","doi-asserted-by":"crossref","DOI":"10.21037\/tgh.2019.09.08","article-title":"Epidemiology of non-alcoholic and alcoholic fatty liver diseases","volume":"5","author":"Mitra","year":"2020","journal-title":"Transl Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2021.07.001_bib2","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1007\/s10620-016-4143-0","article-title":"Global epidemiology of nonalcoholic fatty liver disease and perspectives on US minority populations","volume":"61","author":"Sherif","year":"2016","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jceh.2021.07.001_bib3","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatol Baltim Md"},{"key":"10.1016\/j.jceh.2021.07.001_bib4","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases","volume":"67","author":"Chalasani","year":"2018","journal-title":"Hepatol Baltim Md"},{"key":"10.1016\/j.jceh.2021.07.001_bib5","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgaa575","article-title":"Prevalence of nonalcoholic fatty liver disease (NAFLD) in patients with type 1 Zdiabetes mellitus: a systematic review and meta-analysis","volume":"105","author":"de Vries","year":"2020","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.jceh.2021.07.001_bib6","first-page":"448","article-title":"Study of prevalence of nonalcoholic fatty liver disease (NAFLD) in type 2 diabetes patients in India (SPRINT)","volume":"61","author":"Kalra","year":"2013","journal-title":"J\u00a0Assoc Phys India"},{"key":"10.1016\/j.jceh.2021.07.001_bib7","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.dsx.2020.02.011","article-title":"rs7903146 (C\/T) polymorphism of Transcription factor 7 like 2 (TCF7L-2) gene is independently associated with non-alcoholic fatty liver disease in Asian Indians","volume":"14","author":"Bhatt","year":"2020","journal-title":"Diabetes Metab Syndr"},{"key":"10.1016\/j.jceh.2021.07.001_bib8","doi-asserted-by":"crossref","DOI":"10.1111\/ijpo.12648","article-title":"Increased atherogenic lipoprotein profile in children with non-alcoholic steatohepatitis","volume":"15","author":"Castillo-Leon","year":"2020","journal-title":"Pediatr Obes"},{"key":"10.1016\/j.jceh.2021.07.001_bib9","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.2337\/db12-0858","article-title":"Sterol regulatory element-binding factor 2 (SREBF-2) predicts 7-year NAFLD incidence and severity of liver disease and lipoprotein and glucose dysmetabolism","volume":"62","author":"Musso","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.jceh.2021.07.001_bib10","doi-asserted-by":"crossref","first-page":"4566","DOI":"10.2174\/1381612825666190119113836","article-title":"Genetics of nonalcoholic fatty liver disease: a 2018 update","volume":"24","author":"Valenti","year":"2018","journal-title":"Curr Pharmaceut Des"},{"key":"10.1016\/j.jceh.2021.07.001_bib11","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1016\/j.jhep.2016.01.014","article-title":"Type 2 diabetes and risk of hospital admission or death for chronic liver diseases","volume":"64","author":"Wild","year":"2016","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2021.07.001_bib12","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s12916-019-1321-x","article-title":"Risks and clinical predictors of cirrhosis and hepatocellular carcinoma diagnoses in adults with diagnosed NAFLD: real-world study of 18 million patients in four European cohorts","volume":"17","author":"Alexander","year":"2019","journal-title":"BMC Med"},{"key":"10.1016\/j.jceh.2021.07.001_bib13","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1002\/hep.27981","article-title":"Presence of diabetes mellitus and steatosis is associated with liver stiffness in a general population: the Rotterdam study","volume":"63","author":"Koehler","year":"2016","journal-title":"Hepatol Baltim Md"},{"key":"10.1016\/j.jceh.2021.07.001_bib14","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1038\/ajg.2016.178","article-title":"Metabolically healthy obesity and the development of nonalcoholic fatty liver disease","volume":"111","author":"Chang","year":"2016","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jceh.2021.07.001_bib15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0224626","article-title":"Nonalcoholic fatty liver disease is an early predictor of metabolic diseases in a metabolically healthy population","volume":"14","author":"Yang","year":"2019","journal-title":"PloS One"},{"key":"10.1016\/j.jceh.2021.07.001_bib16","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s12902-020-00582-9","article-title":"Impact of obesity and metabolic health status in the development of non-alcoholic fatty liver disease (NAFLD): a United Kingdom population-based cohort study using the health improvement network (THIN)","volume":"20","author":"Vusirikala","year":"2020","journal-title":"BMC Endocr Disord"},{"key":"10.1016\/j.jceh.2021.07.001_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4103\/ijem.IJEM_225_20","article-title":"RSSDI-ESI clinical practice recommendations for the management of type 2 diabetes mellitus 2020","volume":"24","author":"Chawla","year":"2020","journal-title":"Indian J Endocrinol Metab"},{"key":"10.1016\/j.jceh.2021.07.001_bib18","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1161\/circ.106.25.3143","volume":"106","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.jceh.2021.07.001_bib19","first-page":"1974","article-title":"Association between obesity and discordance in fibrosis stage determination by magnetic resonance vs transient elastography in patients with non-alcoholic liver disease","volume":"16","author":"Caussy","year":"2018","journal-title":"Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc"},{"key":"10.1016\/j.jceh.2021.07.001_bib20","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/hep.24624","article-title":"Feasibility and diagnostic performance of the FibroScan XL probe for liver stiffness measurement in overweight and obese patients","volume":"55","author":"Myers","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2021.07.001_bib22","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jhep.2015.04.006","article-title":"Asociacion Latinoamericana para el Estudio del Higado. EASL-ALEH Clinical Practice Guidelines: non-invasive tests for evaluation of liver disease severity and prognosis","volume":"63","year":"2015","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2021.07.001_bib23","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1053\/jhep.2003.50346","article-title":"A\u00a0simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C","volume":"38","author":"Wai","year":"2003","journal-title":"Hepatol Baltim Md"},{"key":"10.1016\/j.jceh.2021.07.001_bib24","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/hep.21669","article-title":"FIB-4: an inexpensive and accurate marker of fibrosis in HCV infection. comparison with liver biopsy and fibrotest","volume":"46","author":"Vallet-Pichard","year":"2007","journal-title":"Hepatol Baltim Md"},{"key":"10.1016\/j.jceh.2021.07.001_bib25","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1002\/hep.23312","article-title":"Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease","volume":"51","author":"Wong","year":"2010","journal-title":"Hepatol Baltim Md"},{"key":"10.1016\/j.jceh.2021.07.001_bib26","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1002\/hep.21496","article-title":"The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD","volume":"45","author":"Angulo","year":"2007","journal-title":"Hepatol Baltim Md"},{"key":"10.1016\/j.jceh.2021.07.001_bib27","doi-asserted-by":"crossref","first-page":"419","DOI":"10.2337\/dc16-1787","article-title":"Management of nonalcoholic fatty liver disease in patients with type 2 diabetes: a call to action","volume":"40","author":"Bril","year":"2017","journal-title":"Diabetes Care"},{"issue":"suppl 1","key":"10.1016\/j.jceh.2021.07.001_bib28","article-title":"1450-P: high risk of mortality and disease progression associated with diabetes mellitus (DM) and nonalcoholic fatty liver disease\/nonalcoholic steatohepatitis (NAFLD\/NASH) in medicare patients","volume":"68","author":"Loomba","year":"2019","journal-title":"Diabetes"},{"key":"10.1016\/j.jceh.2021.07.001_bib29","first-page":"643","article-title":"Fibrosis progression in nonalcoholic fatty liver vs nonalcoholic steatohepatitis: a systematic review and meta-analysis of paired-biopsy studies","volume":"13","author":"Singh","year":"2015","journal-title":"Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc"},{"key":"10.1016\/j.jceh.2021.07.001_bib30","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/j.jhep.2014.11.034","article-title":"Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: implications for prognosis and clinical management","volume":"62","author":"McPherson","year":"2015","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2021.07.001_bib31","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1111\/jgh.14734","article-title":"Type 2 diabetes mellitus: a risk factor for progression of liver fibrosis in middle-aged patients with non-alcoholic fatty liver disease","volume":"34","author":"Tada","year":"2019","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2021.07.001_bib32","first-page":"2310","article-title":"Prevalence and risk factors of significant fibrosis in patients with nonalcoholic fatty liver without steatohepatitis","volume":"17","author":"Pelusi","year":"2019","journal-title":"Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc"},{"key":"10.1016\/j.jceh.2021.07.001_bib33","article-title":"Occurrence over time and regression of nonalcoholic fatty liver disease in type 2 diabetes","volume":"33","author":"Giorda","year":"2017","journal-title":"Diabetes\u00a0Metab Res Rev"},{"key":"10.1016\/j.jceh.2021.07.001_bib34","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1002\/hep.30886","article-title":"Noninvasive tests of liver fibrosis and their combination in nonalcoholic fatty liver disease: from selected patients to real-life populations","volume":"70","author":"Boursier","year":"2019","journal-title":"Hepatol Baltim Md"}],"container-title":["Journal of Clinical and Experimental Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0973688321001687?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0973688321001687?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T06:11:47Z","timestamp":1760854307000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0973688321001687"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["S0973688321001687"],"URL":"https:\/\/doi.org\/10.1016\/j.jceh.2021.07.001","relation":{},"ISSN":["0973-6883"],"issn-type":[{"value":"0973-6883","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diabetes Mellitus Increases the Risk of Significant Hepatic Fibrosis in Patients With Non-alcoholic Fatty Liver Disease","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical and Experimental Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jceh.2021.07.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Indian National Association for Study of the Liver. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}